Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 907

1.

Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients.

Palumbo C, Knipper S, Pecoraro A, Rosiello G, Luzzago S, Deuker M, Tian Z, Shariat SF, Simeone C, Briganti A, Saad F, Berruti A, Antonelli A, Karakiewicz PI.

Eur J Surg Oncol. 2020 Mar 14. pii: S0748-7983(20)30351-6. doi: 10.1016/j.ejso.2020.03.204. [Epub ahead of print]

PMID:
32220544
2.

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis.

Chys B, Devos G, Everaerts W, Albersen M, Moris L, Claessens F, De Meerleer G, Haustermans K, Briganti A, Chlosta P, Gontero P, Graefen M, Gratzke C, Karnes RJ, Kneitz B, Marchioro G, Salas RS, Spahn M, Tombal B, Van Der Poel H, Walz J, Van Poppel H, Joniau S.

Front Oncol. 2020 Mar 6;10:246. doi: 10.3389/fonc.2020.00246. eCollection 2020.

3.

Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy.

Rosiello G, Palumbo C, Knipper S, Deuker M, Stolzenbach LF, Tian Z, Gandaglia G, Fossati N, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Prostate Cancer Prostatic Dis. 2020 Mar 18. doi: 10.1038/s41391-020-0225-3. [Epub ahead of print]

PMID:
32203071
4.

Converging Roads to Early Bladder Cancer.

Necchi A, Gallina A, Dyrskjøt L, Roupret M, Kamat AM, Spiess PE, Grivas P, Gibb EA, Briganti A, Montorsi F.

Eur Urol. 2020 Mar 17. pii: S0302-2838(20)30141-X. doi: 10.1016/j.eururo.2020.02.031. [Epub ahead of print] No abstract available.

PMID:
32197887
5.

Contemporary rates and predictors of open conversion during minimally invasive radical prostatectomy for non-metastatic prostate cancer.

Luzzago S, Rosiello G, Pecoraro A, Deuker M, Stolzenbach F, Mistretta FA, Tian Z, Musi G, Montanari E, Shariat SF, Saad F, Briganti A, De Cobelli O, Karakiewicz PI.

J Endourol. 2020 Mar 17. doi: 10.1089/end.2020.0074. [Epub ahead of print]

PMID:
32178532
6.

Optimizing the selection of candidates for neoadjuvant chemotherapy among node positive penile squamous cell carcinoma patients.

Bandini M, Albersen M, Chipollini J, Pederzoli F, Zhu Y, Ye DW, Ornellas AA, Watkin N, Ager M, Hakenberg OW, Heidenreich A, Raggi D, Catanzaro M, Haidl F, Mazzone E, Marandino L, Briganti A, Montorsi F, Azizi M, Spiess PE, Necchi A.

BJU Int. 2020 Mar 16. doi: 10.1111/bju.15054. [Epub ahead of print]

PMID:
32175663
7.

Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma.

Pecoraro A, Palumbo C, Knipper S, Rosiello G, Luzzago S, Tian Z, Shariat SF, Saad F, Lavallée L, Briganti A, Kapoor A, Fiori C, Porpiglia F, Karakiewicz PI.

Clin Genitourin Cancer. 2020 Feb 8. pii: S1558-7673(20)30035-5. doi: 10.1016/j.clgc.2020.02.001. [Epub ahead of print]

PMID:
32173357
8.

Adherence to guideline recommendations for multimodality treatment of patients with pT2-3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes.

Mistretta FA, Negrean-Dzyuba C, Palumbo C, Pecoraro A, Knipper S, Tian Z, Musi G, Montanari E, Perrotte P, Briganti A, Shariat SF, Saad F, de Cobelli O, Karakiewicz PI.

Int J Urol. 2020 Mar 14. doi: 10.1111/iju.14206. [Epub ahead of print]

PMID:
32172530
9.

Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database-based Study.

Pecoraro A, Palumbo C, Knipper S, Mistretta FA, Rosiello G, Tian Z, St-Hilaire PA, Shariat SF, Saad F, Lavallée L, Briganti A, Kapoor A, Fiori C, Porpiglia F, Karakiewicz PI.

Eur Urol Focus. 2020 Mar 10. pii: S2405-4569(20)30068-7. doi: 10.1016/j.euf.2020.02.011. [Epub ahead of print]

PMID:
32169361
10.

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer.

Necchi A, Raggi D, Gallina A, Ross JS, Farè E, Giannatempo P, Marandino L, Colecchia M, Lucianò R, Bianchi M, Colombo R, Salonia A, Gandaglia G, Fossati N, Bandini M, Pederzoli F, Capitanio U, Montorsi F, de Jong JJ, Dittamore R, Liu Y, Davicioni E, Boormans JL, Briganti A, Black PC, Gibb EA.

Eur Urol. 2020 Mar 9. pii: S0302-2838(20)30138-X. doi: 10.1016/j.eururo.2020.02.028. [Epub ahead of print]

PMID:
32165065
11.

Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis.

Mori K, Miura N, Mostafaei H, Quhal F, Sari Motlagh R, Pradere B, Kimura S, Kimura T, Egawa S, Briganti A, Karakiewicz PI, Shariat SF.

Prostate Cancer Prostatic Dis. 2020 Mar 9. doi: 10.1038/s41391-020-0222-6. [Epub ahead of print] Review.

PMID:
32152435
12.

Metabolic syndrome predicts worse perioperative outcomes in patients treated with partial nephrectomy for renal cell carcinoma.

Luzzago S, Palumbo C, Rosiello G, Pecoraro A, Deuker M, Stolzenbach F, Mistretta FA, Tian Z, Musi G, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI.

Urology. 2020 Mar 6. pii: S0090-4295(20)30255-7. doi: 10.1016/j.urology.2020.02.019. [Epub ahead of print]

PMID:
32151650
13.

Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities.

Luzzago S, Palumbo C, Rosiello G, Knipper S, Pecoraro A, Nazzani S, Tian Z, Musi G, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Dec 13. pii: S1558-7673(19)30374-X. doi: 10.1016/j.clgc.2019.12.001. [Epub ahead of print]

PMID:
32146153
14.

Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study.

Bandini M, Pederzoli F, Madison R, Briganti A, Ross JS, Niegisch G, Yu EY, Bamias A, Agarwal N, Sridhar SS, Rosenberg JE, Bellmunt J, Pal SK, Galsky MD, Lucianò R, Gallina A, Salonia A, Montorsi F, Ali SM, Chung JH, Necchi A.

Clin Genitourin Cancer. 2020 Feb 8. pii: S1558-7673(20)30033-1. doi: 10.1016/j.clgc.2020.01.007. [Epub ahead of print]

PMID:
32144050
15.

Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis.

Luzzago S, Palumbo C, Rosiello G, Knipper S, Pecoraro A, Mistretta FA, Tian Z, Musi G, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI.

Urol Oncol. 2020 Mar 2. pii: S1078-1439(20)30045-4. doi: 10.1016/j.urolonc.2020.02.004. [Epub ahead of print]

PMID:
32139292
16.

Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy.

Mori K, Janisch F, Mostafaei H, Kimura S, Lysenko I, Karakiewicz PI, Briganti A, Enikeev DV, Rouprêt M, Margulis V, Chlosta P, Nyirady P, Babjuk M, Egawa S, Shariat SF.

Urol Oncol. 2020 Feb 29. pii: S1078-1439(20)30049-1. doi: 10.1016/j.urolonc.2020.02.008. [Epub ahead of print]

PMID:
32127252
17.

Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma.

Rosiello G, Palumbo C, Knipper S, Pecoraro A, Luzzago S, Tian Z, Larcher A, Capitanio U, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Urol Oncol. 2020 Feb 28. pii: S1078-1439(20)30033-8. doi: 10.1016/j.urolonc.2020.01.013. [Epub ahead of print]

PMID:
32122729
18.

Re: Ola Bratt, Erik Holmberg, Ove Andrén, et al. The Value of an Extensive Transrectal Repeat Biopsy with Anterior Sampling in Men on Active Surveillance for Low-risk Prostate Cancer: A Comparison from the Randomised Study of Active Monitoring in Sweden (SAMS). Eur Urol 2019;76:461-6.

Montorsi F, Gandaglia G, Fossati N, Salonia A, Briganti A.

Eur Urol. 2020 Feb 25. pii: S0302-2838(20)30059-2. doi: 10.1016/j.eururo.2020.01.023. [Epub ahead of print] No abstract available.

PMID:
32111414
19.

Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract.

Rosiello G, Palumbo C, Knipper S, Pecoraro A, Luzzago S, Deuker M, Mistretta FA, Tian Z, Fossati N, Gallina A, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

J Surg Oncol. 2020 Feb 27. doi: 10.1002/jso.25877. [Epub ahead of print]

PMID:
32107785
20.

Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution.

Bravi CA, Rosiello G, Fallara G, Vertosick E, Tin A, Sjoberg D, Bianchi M, Mazzone E, Martini A, Dell'oglio P, Stabile A, Gandaglia G, Fossati N, Briganti A, Montorsi F, Vickers A.

Minerva Urol Nefrol. 2020 Feb 19. doi: 10.23736/S0393-2249.20.03662-0. [Epub ahead of print]

PMID:
32083416
21.

Underestimation of PET/CT Scan in Assessing Tumour Burden of Men With Nodal Recurrence From Prostate Cancer: Head-to-Head Comparison OF 68Ga-PSMA and 11C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections.

Fossati N, Scarcella S, Gandaglia G, Suardi N, Robesti D, Boeri L, Karnes RJ, Heidenreich A, Pfister D, Kretschmer A, Buchner A, Stief C, Battaglia A, Joniau S, Van Poppel H, Osmonov D, Juenemann KP, Shariat S, Hiester A, Nini A, Albers P, Tilki D, Graefen M, Gill IS, Mottrie A, Galosi AB, Montorsi F, Briganti A.

J Urol. 2020 Feb 18:101097JU0000000000000800. doi: 10.1097/JU.0000000000000800. [Epub ahead of print]

PMID:
32068488
22.

Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1.

Brembilla G, Dell'Oglio P, Stabile A, Damascelli A, Brunetti L, Ravelli S, Cristel G, Schiani E, Venturini E, Grippaldi D, Mendola V, Rancoita PMV, Esposito A, Briganti A, Montorsi F, Del Maschio A, De Cobelli F.

Eur Radiol. 2020 Feb 12. doi: 10.1007/s00330-019-06654-2. [Epub ahead of print]

PMID:
32052171
23.

Extended pelvic lymph-node dissection is independently associated with improved overall survival in patients with prostate cancer at high-risk of lymph-node invasion.

Sood A, Keeley J, Palma-Zamora I, Dalela D, Arora S, Peabody JO, Rogers CG, Montorsi F, Menon M, Briganti A, Abdollah F.

BJU Int. 2020 Feb 11. doi: 10.1111/bju.15034. [Epub ahead of print] No abstract available.

PMID:
32045096
24.

Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration.

Soria F, Giordano A, D'Andrea D, Moschini M, Rouprêt M, Margulis V, Karakiewicz PI, Briganti A, Bensalah K, Mathieu R, Chlosta P, Babjuk M, Glybochko PV, Enikeev DV, Remzi M, Gust K, Gontero P, Shariat SF.

Urol Oncol. 2020 Feb 6. pii: S1078-1439(20)30005-3. doi: 10.1016/j.urolonc.2020.01.004. [Epub ahead of print]

PMID:
32037197
26.

Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study.

Luzzago S, Palumbo C, Rosiello G, Knipper S, Pecoraro A, Deuker M, Mistretta FA, Tian Z, Musi G, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Oct 16. pii: S1558-7673(19)30320-9. doi: 10.1016/j.clgc.2019.10.016. [Epub ahead of print]

PMID:
32035800
27.

Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients.

Buti S, Karakiewicz PI, Bersanelli M, Capitanio U, Tian Z, Cortellini A, Taguchi S, Briganti A, Montorsi F, Leonardi F, Bandini M.

Sci Rep. 2020 Feb 5;10(1):2304. doi: 10.1038/s41598-020-59358-9.

28.

Prognostic Value of Hemoglobin in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.

Mori K, Janisch F, Mostafaei H, Lysenko I, Karakiewicz PI, Enikeev DV, Briganti A, Kimura S, Egawa S, Shariat SF.

Clin Genitourin Cancer. 2019 Dec 13. pii: S1558-7673(19)30375-1. doi: 10.1016/j.clgc.2019.12.002. [Epub ahead of print] Review.

PMID:
32007439
29.

Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.

Mistretta FA, Cyr SJ, Luzzago S, Mazzone E, Knipper S, Palumbo C, Tian Z, Nazzani S, Saad F, Montanari E, Tilki D, Briganti A, Shariat SF, de Cobelli O, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Sep 26. pii: S1558-7673(19)30277-0. doi: 10.1016/j.clgc.2019.09.008. [Epub ahead of print]

PMID:
32001182
30.

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.

Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A.

Eur Urol. 2020 Apr;77(4):508-547. doi: 10.1016/j.eururo.2020.01.012. Epub 2020 Jan 27.

31.

Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities.

Luzzago S, Palumbo C, Rosiello G, Knipper S, Pecoraro A, Nazzani S, Tian Z, Musi G, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI.

Cancer Causes Control. 2020 Mar;31(3):263-272. doi: 10.1007/s10552-020-01270-8. Epub 2020 Jan 28.

PMID:
31993859
32.

European Association of Urology Guidelines Office: How We Ensure Transparent Conflict of Interest Disclosure and Management.

Smith EJ, Plass K, Darraugh J, Shepherd R, Briganti A, Cornford P, Knoll T, Lumen N, N'Dow J, Ribal MJ, Sylvester R, van Poppel H, Bjartell A; EAU Guidelines Office Panel Chairs.

Eur Urol. 2020 Apr;77(4):397-399. doi: 10.1016/j.eururo.2020.01.010. Epub 2020 Jan 25.

PMID:
31992464
33.

Renal Function Assessment Gap in Clinical Practice: An Awkward Truth.

Trevisani F, Di Marco F, Capitanio U, Larcher A, Bettiga A, Dosio F, Ghidini M, Del Conte G, Vago R, Cinque A, Gianolli L, Salonia A, Briganti A, Luis-Lima S, Negrín-Mena N, Montorsi F, Porrini E.

Kidney Blood Press Res. 2020;45(2):166-179. doi: 10.1159/000504649. Epub 2020 Jan 24.

34.

Re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14.

Montorsi F, Fossati N, Gandaglia G, Briganti A.

Eur Urol. 2020 Apr;77(4):e107. doi: 10.1016/j.eururo.2020.01.015. Epub 2020 Jan 21. No abstract available.

PMID:
31980310
35.

Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder.

Luzzago S, Palumbo C, Rosiello G, Pecoraro A, Deuker M, Mistretta FA, Tian Z, Musi G, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI.

World J Urol. 2020 Jan 20. doi: 10.1007/s00345-020-03083-5. [Epub ahead of print]

PMID:
31960108
36.

Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients.

Stangl-Kremser J, Mari A, Suarez-Ibarrola R, D'Andrea D, Korn SM, Pones M, Kramer G, Karakiewicz P, Enikeev DV, Glybochko PV, Briganti A, Shariat SF.

Urol Oncol. 2020 Jan 14. pii: S1078-1439(19)30478-8. doi: 10.1016/j.urolonc.2019.11.005. [Epub ahead of print]

PMID:
31953003
37.

Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy.

Rosiello G, Palumbo C, Deuker M, Stolzenbach LF, Tian Z, Larcher A, Capitanio U, Montorsi F, Shariat SF, Kapoor A, Saad F, Briganti A, Karakiewicz PI.

J Surg Oncol. 2020 Mar;121(4):688-696. doi: 10.1002/jso.25840. Epub 2020 Jan 12.

PMID:
31930511
38.

Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial.

Briganti A, Gandaglia G, Scuderi S, Gallina A, Colombo R, Fossati N, Barletta F, Pellegrino A, Nocera L, Montorsi F, Necchi A.

Eur Urol. 2020 Jan 3. pii: S0302-2838(19)30963-7. doi: 10.1016/j.eururo.2019.12.019. [Epub ahead of print]

PMID:
31911010
39.

Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy.

Palumbo C, Mistretta FA, Knipper S, Pecoraro A, Tian Z, Shariat SF, Saad F, Simeone C, Briganti A, Antonelli A, Karakiewicz PI.

J Natl Compr Canc Netw. 2020 Jan;18(1):44-51. doi: 10.6004/jnccn.2019.7350.

PMID:
31910387
40.

Efficacy of Preoperative Chemotherapy in High Risk Upper Tract Urothelial Carcinoma.

Foerster B, Abufaraj M, Petros F, Azizi M, Gupta M, Schweitzer D, Margulis V, Iwata T, Kimura S, Shabsigh A, Briganti A, Ku JH, Muilwijk T, Kassouf W, Matin SF, Spiess PE, Pierorazio PM, Hendricksen K, Shariat SF.

J Urol. 2020 Jan 2:101097JU0000000000000737. doi: 10.1097/JU.0000000000000737. [Epub ahead of print]

PMID:
31898919
41.

Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study.

Necchi A, Bandini M, Calareso G, Raggi D, Pederzoli F, Farè E, Colecchia M, Marandino L, Bianchi M, Gallina A, Colombo R, Fossati N, Gandaglia G, Capitanio U, Dehò F, Giannatempo P, Lucianò R, Salonia A, Madison R, Ali SM, Chung JH, Ross JS, Briganti A, Montorsi F, De Cobelli F, Messina A.

Eur Urol. 2019 Dec 24. pii: S0302-2838(19)30960-1. doi: 10.1016/j.eururo.2019.12.016. [Epub ahead of print]

PMID:
31882281
42.

Continuous positive airway pressure (CPAP) provision with a pediatric helmet for treatment of hypoxemic acute respiratory failure in dogs.

Ceccherini G, Lippi I, Citi S, Perondi F, Pamapanini M, Guidi G, Briganti A.

J Vet Emerg Crit Care (San Antonio). 2020 Jan;30(1):41-49. doi: 10.1111/vec.12920. Epub 2019 Dec 23.

PMID:
31872531
43.

Dose-dependent effect of romifidine on intraocular pressure in clinically healthy buffalo (Bubalus bubalis).

Rizk A, Nocera I, Briganti A, Abouelnasr K, El-Khodery S, Tagawa M, Bonelli F.

Heliyon. 2019 Dec 4;5(12):e02930. doi: 10.1016/j.heliyon.2019.e02930. eCollection 2019 Dec.

44.

Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy.

Martini A, Fossati N, Karnes RJ, Boorjian SA, Boeri L, Bossi A, Di Muzio N, Cozzarini C, Noris Chiorda B, Gandaglia G, Robesti D, Bartkowiak D, Böhmer D, Shariat SF, Goldner G, Battaglia A, Joniau S, Berghen C, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Wiegel T, Briganti A.

Eur Urol Oncol. 2019 Dec 3. pii: S2588-9311(19)30162-2. doi: 10.1016/j.euo.2019.11.003. [Epub ahead of print]

PMID:
31810893
45.

Prevalence and surgical management of pubic hypertrophy in hypospadias patients: results from a high-volume surgeon.

Bandini M, Sekulovic S, Stanojevic N, Spiridonescu B, Pesic V, Sansalone S, Slavkovic M, Briganti A, Salonia A, Montorsi F, Djinovic R.

Int Braz J Urol. 2019 Nov-Dec;45(6):1238-1248. doi: 10.1590/S1677-5538.IBJU.2019.0267.

46.

Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer.

Kimura S, D'Andrea D, Iwata T, Foerster B, Janisch F, Parizi MK, Moschini M, Briganti A, Babjuk M, Chlosta P, Karakiewicz PI, Enikeev D, Rapoport LM, Seebacher V, Egawa S, Abufaraj M, Shariat SF.

World J Urol. 2019 Dec 4. doi: 10.1007/s00345-019-03038-5. [Epub ahead of print]

PMID:
31797075
47.

Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy.

Preisser F, Mazzone E, Knipper S, Nazzani S, Bandini M, Shariat SF, Marchioni M, Tian Z, Saad F, Taussky D, Briganti A, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Can Urol Assoc J. 2019 Nov 29. doi: 10.5489/cuaj.6087. [Epub ahead of print]

PMID:
31793866
48.

Effect of topical ophthalmic instillation of rocuronium bromide on the intraocular pressure of kestrels (Falco tinnunculus) and little owls (Athene noctuae).

Barsotti G, Asti M, Giani E, Ceccherelli R, Briganti A.

J Am Vet Med Assoc. 2019 Dec 15;255(12):1359-1364. doi: 10.2460/javma.255.12.1359.

PMID:
31793838
49.

Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer.

Rosiello G, Palumbo C, Knipper S, Pecoraro A, Dzyuba-Negrean C, Luzzago S, Tian Z, Gallina A, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Urol Oncol. 2020 Mar;38(3):76.e1-76.e9. doi: 10.1016/j.urolonc.2019.10.018. Epub 2019 Nov 21.

PMID:
31761614
50.

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A.

Eur Urol. 2020 Feb;77(2):223-250. doi: 10.1016/j.eururo.2019.09.035. Epub 2019 Nov 19.

PMID:
31753752

Supplemental Content

Loading ...
Support Center